Agnieszka Pajak, a REPROGRAM-dedicated PhD-student working at the University Hospital Zurich (Switzerland) on Trained Immunity in rheumatoid arthritis was invited to give a talk at the Annual European Congress of Rheumatology (European League Against Rheumatism, EULAR). The following EULAR congress is planned in Amsterdam (the Netherlands) from 13 till 16 June 2018.
Every year The Radboud Center for Infectious Diseases organizes the international symposium ‘Summer Frontiers of Science’ on a cutting edge subject in infection and immunology. www.radboudumc.nl/summerfrontiers The subject of ‘Systems Biology of Innate Immunity’ will cover novel aspects on functional genomics, epigenomics, transcriptomics, microbiome and immunometabolism, related to the understanding of innate immune responses.
The European Atherosclerosis Society’s goal is to provide a framework for concerted scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis. EAS is active in the publication of Guidelines and Consensus Position Papers, and its official Journal is Atherosclerosis. Through a regular series of Featured Commentaries EAS puts into
AMC Researchers Siroon Bekkering and Simone Verweij both awarded Best Presentor at the Lipoprotein(a) Satellite Meeting (From Bench to Bedside) in Innsbruck (2016). The AMC department of Vascular Medicine (Erik Stroes) is imbedded in the department of Internal Medicine, and has a strong focus on translational research aimed at pathophysiology, diagnosis and treatment of atherosclerotic
Prof. Matthias Nahrendorf (Harvard Medical School), a key-partner within the REPROGRAM in collaboration with Prof. Filip K. Swirski published a scientific article in the European Heart Journal (Impact factor 15.2) on a topic highly related to REPROGRAM. You will find his article here .